The spectrum of biopsy-proven glomerular diseases in a tertiary Hospital in Southern Brazil

por Thomé, Gustavo Gomes, Bianchini, Talissa, Bringhenti, Rafael Nazario, Schaefer, Pedro Guilherme, Barros, Elvino José Guardão, Veronese, Francisco Veríssimo
Publicado 2021

Reference values for glomerular filtration rate in healthy Brazilian adults

por Soares, Ariana Aguiar, Prates, Aline Bodanese, Weinert, Letícia Schwerz, Veronese, Francisco Veríssimo, Azevedo, Mirela Jobim de, Silveiro, Sandra Pinho
Publicado 2013

Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations

por Giudicelli, Giovanna Câmara, De Souza, Celia Mariana Barbosa, Veronese, Francisco Veríssimo, Pereira, Lygia V., Hünemeier, Tábita, Vianna, Fernanda Sales Luiz
Publicado 2022

Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy

por Nogare, Aline Lima, Veronese, Francisco Veríssimo, Carpio, Virna Nowotny, Montenegro, Rosangela Munhoz, Pedroso, José Alberto, Pegas, Karla Laís, Gonçalves, Luiz Felipe, Manfro, Roberto Ceratti
Publicado 2015

Anticoagulant-related nephropathy: systematic review and meta-analysis

por de Aquino Moura, Karolinny Borinelli, Behrens, Paula Marques Prates, Pirolli, Rafaela, Sauer, Aimee, Melamed, Dayana, Veronese, Francisco Veríssimo, da Silva, André Luis Ferreira Azeredo
Publicado 2019

Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis

por Gasparin, Andrese Aline, de Andrade, Nicole Pamplona Bueno, Hax, Vanessa, Palominos, Penélope Esther, Siebert, Marina, Marx, Romulo, Schaefer, Pedro Guilherme, Veronese, Francisco Veríssimo, Monticielo, Odirlei André
Publicado 2020

Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?

por Lopes, Tiago Giulianni, de Souza, Maysa Lucena, da Silva, Vinicius Duval, dos Santos, Mariane, da Silva, William Israel Cardoso, Itaquy, Thiago Pereira, Garbin, Henrique Iahnke, Veronese, Francisco Veríssimo
Publicado 2019

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

por Vincenti, Flavio, Fervenza, Fernando C., Campbell, Kirk N., Diaz, Montserrat, Gesualdo, Loreto, Nelson, Peter, Praga, Manuel, Radhakrishnan, Jai, Sellin, Lorenz, Singh, Ajay, Thornley-Brown, Denyse, Veronese, Francisco Veríssimo, Accomando, Beverly, Engstrand, Sara, Ledbetter, Steven, Lin, Julie, Neylan, John, Tumlin, James
Publicado 2017